115 related articles for article (PubMed ID: 11902489)
1. Therapeutic results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: its usefulness and controversial points.
Fuwa N; Ito Y; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H; Sasaoka M; Morita K
Jpn J Clin Oncol; 2001 Dec; 31(12):589-95. PubMed ID: 11902489
[TBL] [Abstract][Full Text] [Related]
2. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results.
Tan EH; Chua ET; Wee J; Tan T; Fong KW; Ang PT; Lee KS; Lee KM; Khoo-Tan HS; Leong SS; Ong YK; Foo KF; Sethi VK; Chua EJ
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):597-601. PubMed ID: 10524411
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
[TBL] [Abstract][Full Text] [Related]
8. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: a preliminary report of phase II study.
Fuwa N; Kano M; Toita T; Shikama N; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H
Radiother Oncol; 2001 Dec; 61(3):257-60. PubMed ID: 11730994
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer.
Lin JC; Jan JS; Hsu CY
Am J Clin Oncol; 1997 Feb; 20(1):6-10. PubMed ID: 9020279
[TBL] [Abstract][Full Text] [Related]
10. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432
[TBL] [Abstract][Full Text] [Related]
11. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with daily low dose intra-arterial cisplatin plus 5-fluorouracil for stage IV nasopharyngeal cancer.
Kohno N; Ohno Y; Kitahara S; Tamura E; Tanabe T; Murata Y; Kawaida M
Singapore Med J; 2003 Aug; 44(8):410-3. PubMed ID: 14700420
[TBL] [Abstract][Full Text] [Related]
13. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
Hu QY; Liu P; Wang L; Fu ZF
Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting outcomes of alternating chemoradiotherapy for nasopharyngeal cancer.
Ueno T; Endo K; Kondo S; Wakisaka N; Murono S; Ito M; Yoshizaki T
Ann Otol Rhinol Laryngol; 2014 Jul; 123(7):509-16. PubMed ID: 24634152
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
Al-Sarraf M; LeBlanc M; Giri PG; Fu KK; Cooper J; Vuong T; Forastiere AA; Adams G; Sakr WA; Schuller DE; Ensley JF
J Clin Oncol; 1998 Apr; 16(4):1310-7. PubMed ID: 9552031
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
18. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
Chen Y; Sun Y; Liang SB; Zong JF; Li WF; Chen M; Chen L; Mao YP; Tang LL; Guo Y; Lin AH; Liu MZ; Ma J
Cancer; 2013 Jun; 119(12):2230-8. PubMed ID: 23576020
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
